Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$242M Buy
907,827
+59,767
+7% +$16.5M 0.04% 529
2025
Q4
$233M Sell
848,060
-20,176
-2% -$5.66M 0.04% 504
2025
Q3
$250M Buy
868,236
+44,907
+5% +$13.3M 0.04% 471
2025
Q2
$272M Sell
823,329
-207,898
-20% -$67M 0.05% 401
2025
Q1
$339M Buy
1,031,227
+71,839
+7% +$21.6M 0.06% 312
2024
Q4
$265M Buy
959,388
+229,210
+31% +$73.1M 0.05% 390
2024
Q3
$253M Buy
730,178
+96,986
+15% +$33.4M 0.06% 320
2024
Q2
$209M Buy
633,192
+28,700
+5% +$9.9M 0.05% 336
2024
Q1
$220M Buy
604,492
+242,700
+67% +$79.9M 0.05% 335
2023
Q4
$108M Sell
361,792
-187,157
-34% -$54.7M 0.03% 541
2023
Q3
$157M Buy
548,949
+57,248
+12% +$16.3M 0.05% 351
2023
Q2
$138M Buy
491,701
+128,443
+35% +$33.4M 0.05% 384
2023
Q1
$92.8M Sell
363,258
-111,697
-24% -$32.5M 0.03% 488
2022
Q4
$157M Buy
474,955
+191,010
+67% +$60.4M 0.06% 334
2022
Q3
$78.8M Sell
283,945
-75,962
-21% -$21.4M 0.03% 513
2022
Q2
$94.8M Sell
359,907
-139,640
-28% -$36M 0.04% 464
2022
Q1
$120M Sell
499,547
-11,771
-2% -$2.76M 0.04% 460
2021
Q4
$117M Buy
511,318
+156,109
+44% +$33.2M 0.03% 537
2021
Q3
$71.1M Sell
355,209
-54,175
-13% -$11.8M 0.02% 684
2021
Q2
$97.1M Buy
409,384
+96,271
+31% +$24M 0.03% 531
2021
Q1
$75.7M Sell
313,113
-96,119
-23% -$21.4M 0.03% 622
2020
Q4
$85.2M Sell
409,232
-6,960
-2% -$1.37M 0.03% 539
2020
Q3
$70.5M Buy
416,192
+17,366
+4% +$3.06M 0.03% 512
2020
Q2
$74.8M Buy
398,826
+68,938
+21% +$13.1M 0.03% 449
2020
Q1
$58.5M Sell
329,888
-252,358
-43% -$49M 0.03% 488
2019
Q4
$119M Buy
582,246
+78,582
+16% +$14.4M 0.04% 396
2019
Q3
$76.5M Buy
503,664
+99,151
+25% +$16.1M 0.03% 496
2019
Q2
$63.7M Buy
404,513
+74,493
+23% +$11.7M 0.02% 560
2019
Q1
$53.1M Sell
330,020
-123,180
-27% -$22.5M 0.02% 599
2018
Q4
$86.1M Buy
453,200
+298,446
+193% +$62.3M 0.04% 415
2018
Q3
$32.2M Sell
154,754
-699,611
-82% -$130M 0.01% 898
2018
Q2
$145M Buy
854,365
+720,267
+537% +$125M 0.06% 293
2018
Q1
$22.5M Sell
134,098
-172,844
-56% -$33.6M 0.01% 1072
2017
Q4
$62.3M Buy
306,942
+74,965
+32% +$14.9M 0.03% 583
2017
Q3
$43.4M Sell
231,977
-22,544
-9% -$4.01M 0.02% 668
2017
Q2
$42.6M Sell
254,521
-138,499
-35% -$22.3M 0.02% 637
2017
Q1
$57.6M Sell
393,020
-131,297
-25% -$19.3M 0.03% 503
2016
Q4
$69.9M Sell
524,317
-42,936
-8% -$5.62M 0.04% 424
2016
Q3
$73.9M Sell
567,253
-600,501
-51% -$78.4M 0.04% 403
2016
Q2
$149M Sell
1,167,754
-28,358
-2% -$3.74M 0.09% 224
2016
Q1
$164M Buy
1,196,112
+472,322
+65% +$64.9M 0.11% 199
2015
Q4
$106M Buy
723,790
+291,451
+67% +$40.1M 0.07% 281
2015
Q3
$58.4M Buy
432,339
+155,506
+56% +$22.6M 0.04% 420
2015
Q2
$44.8M Buy
276,833
+32,931
+14% +$4.55M 0.03% 561
2015
Q1
$31.6M Sell
243,902
-14,554
-6% -$1.69M 0.02% 709
2014
Q4
$26.6M Buy
+258,456
New +$25.5M 0.02% 837

Other funds holding CI

UBS Group's CI Position: Q1 2026 in Review

UBS Group increased its Cigna (CI) stake by 7% in Q1 2026, buying an estimated $16.5M and bringing the position to 907,827 shares worth $242M. The position accounts for 0.04% of the portfolio, ranked #529.

UBS Group first reported a position in CI in Q4 2014 and has held it in 46 quarters since. The position peaked at $339M in Q1 2025. 1,655 funds tracked by Wall St. Rank hold CI as of Q1 2026.

  • UBS Group held 907,827 shares of Cigna worth $242M as of Q1 2026.
  • UBS Group bought 59,767 Cigna shares in Q1 2026, an estimated $16.5M.
  • Cigna made up 0.04% of UBS Group's portfolio in Q1 2026, its #529 holding.
  • UBS Group first reported a position in Cigna in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's Cigna position peaked at $339M in Q1 2025.
  • 1,655 funds tracked by Wall St. Rank held Cigna as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.